Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2
Top Cited Papers
- 1 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pediatric Drugs
- Vol. 23 (2), 119-129
- https://doi.org/10.1007/s40272-020-00435-x
Abstract
Although data on the incidence and severity of new coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection showed more significant disease among adults and the elderly, a clinical manifestation characterized by a multisystem inflammatory syndrome was described in children (MIS-C). It was initially thought to be specific to children, but recent reports have shown that it can also occur in adults. MIS-C is characterized by a number of multisystemic manifestations resembling other known previously described illnesses, mainly Kawasaki disease, especially in cases with shock, toxic shock syndrome, and macrophage activation syndrome. Available literature shows that our knowledge of MIS-C is largely incomplete. Its development in strict relation with SARS-CoV-2 infection seems documented and, in most cases, can be considered a post-infectious manifestation secondary to an abnormal immune response for some aspects, similar to that seen in adults several days after SARS-CoV-2 infection. However, in a minority of cases, a clinical picture with symptoms fulfilling criteria for MIS-C diagnosis develops during the acute phase of SARS-CoV-2 infection. It is highly likely that the criteria currently used to diagnose MIS-C are too broad, meaning that children with different diseases are included. As clarity on the pathogenesis of MIS-C is lacking, different therapeutic approaches have been used, but no specific therapy is currently available. Further studies are urgently needed to improve our definition of MIS-C, to define the real impact on child health, and to elucidate the best clinical and therapeutic approach and true prognosis.This publication has 86 references indexed in Scilit:
- The genetics of Kawasaki diseaseInternational Journal of Rheumatic Diseases, 2018
- Concurrent Respiratory Viruses and Kawasaki DiseasePEDIATRICS, 2015
- Population-based Study of Kawasaki Disease Shock Syndrome in TaiwanThe Pediatric Infectious Disease Journal, 2013
- Seasonality of Kawasaki Disease: A Global PerspectivePLOS ONE, 2013
- The role of infection in Kawasaki syndromeJournal of Infection, 2013
- Recognition of a Kawasaki Disease Shock SyndromePEDIATRICS, 2009
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart AssociationPEDIATRICS, 2004
- Diagnosis, Treatment, and Long-Term Management of Kawasaki DiseaseCirculation, 2004
- Toxic Shock Syndrome and Bacterial Superantigens: An UpdateAnnual Review of Microbiology, 2001
- The detection of ventricular dysfunction and carditis in children with Kawasaki disease using equilibrium multigated blood pooling ventriculography and 99Tcm-HMPAO-labelled WBC heart scansNuclear Medicine Communications, 1993